Earnings Feed
Start Free
Home/Insiders/NEELS GUIDO J
NG
SEC Insider//CIK 0001222362

NEELS GUIDO J

CIK 00012223629 companiesGAITHERSBURG, MD
SEC Profile

Transactions

50

Companies

9

Filings

10

CIK

0001222362

Recent Transactions

50 trades
  • Award
    ELUTIA INC.$ELUT

    Stock Option (Right to Buy)

    2026-06-11+106,393→ 106,393 total
  • Award
    TELA Bio, Inc.$TELA

    Common Stock

    2026-06-09+11,925→ 11,925 total
  • Award
    TELA Bio, Inc.$TELA

    Stock Option (Right to Buy)

    2026-06-09+17,335→ 17,335 total
  • Award
    TELA Bio, Inc.$TELA

    Common Stock

    2026-06-09+11,675→ 23,600 total
  • Award
    TELA Bio, Inc.$TELA

    Stock Option (Right to Buy)

    2026-06-09+17,550→ 17,550 total
  • Award
    Bioventus Inc.$BVS

    Restricted Stock Units

    2026-06-03+25,146→ 25,146 total
  • Exercise/Conversion
    Bioventus Inc.$BVS

    Class A Common Stock

    2026-06-02+32,282→ 117,523 total
  • Exercise/Conversion
    Bioventus Inc.$BVS

    Restricted Stock Units

    2026-06-02−32,282→ 0 total
  • Purchase
    ELUTIA INC.$ELUT

    Class A Common Stock

    2026-01-30$1.04/sh+20,000→ 118,750 total
  • Purchase
    ELUTIA INC.$ELUT

    Class A Common Stock

    2026-01-29$1.06/sh+15,000→ 98,750 total
  • Purchase
    ELUTIA INC.$ELUT

    Class A Common Stock

    2026-01-28$1.06/sh+15,000→ 83,750 total
  • Exercise/Conversion
    ELUTIA INC.$ELUT

    Restricted Stock Units

    2025-12-10−6,250→ 0 total
  • Exercise/Conversion
    ELUTIA INC.$ELUT

    Class A Common Stock

    2025-12-10+6,250→ 125,000 total
  • Exercise/Conversion
    ELUTIA INC.$ELUT

    Restricted Stock Units

    2025-12-01−6,250→ 0 total
  • Exercise/Conversion
    ELUTIA INC.$ELUT

    Class A Common Stock

    2025-12-01+6,250→ 68,750 total
  • Award
    ELUTIA INC.$ELUT

    Stock Option (Right to Buy)

    2025-10-09+171,916→ 171,916 total
  • Sale
    Axogen, Inc.$AXGN

    Common Stock

    2025-06-09$10.61/sh−4,073→ 86,743 total
  • Award
    Bioventus Inc.$BVS

    Restricted Stock Units

    2025-06-03+32,282→ 32,282 total
  • Exercise/Conversion
    Bioventus Inc.$BVS

    Restricted Stock Units

    2025-06-02−26,493→ 0 total
  • Exercise/Conversion
    Bioventus Inc.$BVS

    Class A Common Stock

    2025-06-02+26,493→ 85,241 total
  • Exercise/Conversion
    Axogen, Inc.$AXGN

    Common Stock

    2024-09-01+11,904→ 90,816 total
  • Exercise/Conversion
    Axogen, Inc.$AXGN

    Restricted Stock Units

    2024-09-01−11,904→ 0 total
  • Award
    Bioventus Inc.$BVS

    Restricted Stock Units

    2024-06-11+26,493→ 26,493 total
  • Exercise/Conversion
    Bioventus Inc.$BVS

    Restricted Stock Units

    2024-06-07−30,400→ 0 total
  • Exercise/Conversion
    Bioventus Inc.$BVS

    Class A Common Stock

    2024-06-07+30,400→ 58,748 total
  • Award
    Axogen, Inc.$AXGN

    Common Stock

    2024-06-06+10,653→ 78,912 total
  • Award
    Axogen, Inc.$AXGN

    Employee Stock Option (right to purchase)

    2024-06-06+18,248→ 18,248 total
  • Award
    Axogen, Inc.$AXGN

    Stock Option (right to purchase)

    2023-09-01+20,436→ 20,436 total
  • Award
    Axogen, Inc.$AXGN

    Restricted Stock Units

    2023-09-01+11,904→ 11,904 total
  • Purchase
    Axogen, Inc.$AXGN

    Common Stock

    2023-08-16$6.11/sh+10,000→ 68,259 total
  • Award
    Bioventus Inc.$BVS

    Restricted Stock Units

    2023-06-07+30,400→ 30,400 total
  • Exercise/Conversion
    Bioventus Inc.$BVS

    Restricted Stock Units

    2023-06-06−16,648→ 0 total
  • Exercise/Conversion
    Bioventus Inc.$BVS

    Class A Common Stock

    2023-06-06+16,648→ 28,348 total
  • Exercise/Conversion
    Axogen, Inc.$AXGN

    Restricted Stock Units

    2023-06-01−6,459→ 0 total
  • Exercise/Conversion
    Axogen, Inc.$AXGN

    Common Stock

    2023-06-01+6,459→ 58,259 total
  • Award
    Bioventus Inc.$BVS

    Restricted Stock Units

    2022-06-17+16,648→ 16,648 total
  • Exercise/Conversion
    Axogen, Inc.$AXGN

    Restricted Stock Units

    2022-06-01−3,036→ 0 total
  • Award
    Axogen, Inc.$AXGN

    Stock Option (right to purchase)

    2022-06-01+11,811→ 11,811 total
  • Exercise/Conversion
    Axogen, Inc.$AXGN

    Common Stock

    2022-06-01+3,036→ 51,800 total
  • Award
    Axogen, Inc.$AXGN

    Restricted Stock Units

    2022-06-01+6,459→ 6,459 total
  • Exercise/Conversion
    Bioventus Inc.$BVS

    Restricted Stock Units

    2022-04-01−2,700→ 0 total
  • Exercise/Conversion
    Bioventus Inc.$BVS

    Class A Common Stock

    2022-04-01+2,700→ 11,700 total
  • Exercise/Conversion
    Bioventus Inc.$BVS

    Restricted Stock Units

    2022-02-11−9,000→ 0 total
  • Exercise/Conversion
    Bioventus Inc.$BVS

    Class A Common Stock

    2022-02-11+9,000→ 9,000 total
  • Award
    Axogen, Inc.$AXGN

    Stock Option (right to purchase)

    2021-06-01+6,030→ 6,030 total
  • Exercise/Conversion
    Axogen, Inc.$AXGN

    Common Stock

    2021-06-01+6,173→ 48,764 total
  • Exercise/Conversion
    Axogen, Inc.$AXGN

    Restricted Stock Units

    2021-06-01−6,173→ 0 total
  • Award
    Axogen, Inc.$AXGN

    Restricted Stock Units

    2021-06-01+3,036→ 3,036 total
  • Exercise/Conversion
    Axogen, Inc.$AXGN

    Stock Option (right to buy)

    2021-05-19$3.80/sh−25,000→ 0 total
  • Exercise/Conversion
    Axogen, Inc.$AXGN

    Common Stock

    2021-05-19$3.80/sh+25,000→ 27,591 total

Companies

9

Recent Filings

10

Address

20 FIRSTFIELD ROAD

GAITHERSBURG, MD, 20878

View on SEC.gov